Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T07:15:37.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:21.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now includes an additional condition keyword 'Fallopian tube cancer' and a new resource link to the Genetic and Rare Diseases Information Center. The page revision is updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T02:25:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a revision from v3.4.0 to v3.4.1, indicating a backend/template update. No study data, eligibility criteria, or results are altered, and To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:38:48.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The changes are minor UI/metadata updates including the addition of a glossary display and revised footer/version information (e.g., Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:26:16.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous v3.3.3. No study data, eligibility criteria, or key content appears to be altered.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.